Jefferies Group CLDX Holdings History
Jefferies Group's Celldex Therapeutics Inc Holding Summary
As of 2025-03-31, Leucadia National held 55,000.00 shares of Celldex Therapeutics Inc(CLDX), totaling $998,250.00. This investment constitutes 0.01% of their stock portfolio, and Leucadia National now holds 0.08% of the outstanding Celldex Therapeutics Inc(CLDX) stock.
The initial trade took place in 2022Q4. And since then Jefferies Group has made 3 purchases of CLDX, at an average price of $27.27, for a total of 2.41 Mil shares. In addition, there have been 3 sales at an average price of $22.53 for 2.36 Mil shares. Based on historical transaction data and CLDX's current price of $23.36, Jefferies Group's estimated gain on his CLDX holdings is $-11.39 Mil, reflecting a -17.30% gain to date.
Jefferies Group CLDX ($23.36) Holding Chart
Jefferies Group CLDX ($23.36) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
